PDG17 COST-EFFECTIVENESS ANALYSIS OF ARSENIC TRIOXYDE FOR FIRST LINE TREATMENT OF ACUTE PROMYELOCTIC LEUKEMIA

Abstract

Authors

L. Cabrit A. Pages M. pierre-Luc F. Puisset S. Bertoli L. Molinier C. Recher

Full Text Cite This Article
Back to Volume 23, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×